193 related articles for article (PubMed ID: 21921041)
21. Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma.
Song TL; Nairismägi ML; Laurensia Y; Lim JQ; Tan J; Li ZM; Pang WL; Kizhakeyil A; Wijaya GC; Huang DC; Nagarajan S; Chia BK; Cheah D; Liu YH; Zhang F; Rao HL; Tang T; Wong EK; Bei JX; Iqbal J; Grigoropoulos NF; Ng SB; Chng WJ; Teh BT; Tan SY; Verma NK; Fan H; Lim ST; Ong CK
Blood; 2018 Sep; 132(11):1146-1158. PubMed ID: 30054295
[TBL] [Abstract][Full Text] [Related]
22. Primary ophthalmic natural killer/T-cell lymphoma: A population-based study.
Loap P; Kirova Y; Dendale R
Bull Cancer; 2024 Mar; 111(3):310-313. PubMed ID: 38199833
[TBL] [Abstract][Full Text] [Related]
23. Differential microRNA expression between decidual and peripheral blood natural killer cells in early pregnancy.
Carlino C; Rippo MR; Lazzarini R; Monsurrò V; Morrone S; Angelini S; Trotta E; Stabile H; Bastianelli C; Albertini MC; Olivieri F; Procopio A; Santoni A; Gismondi A
Hum Reprod; 2018 Dec; 33(12):2184-2195. PubMed ID: 30388265
[TBL] [Abstract][Full Text] [Related]
24. BCL11A Is Oncogenic and Predicts Poor Outcomes in Natural Killer/T-Cell Lymphoma.
Shi H; Li C; Feng W; Yue J; Song J; Peng A; Wang H
Front Pharmacol; 2020; 11():820. PubMed ID: 32625084
[TBL] [Abstract][Full Text] [Related]
25. Positron emission tomography/computed tomography in the diagnosis, staging, and prognostic evaluation of natural killer/T-cell lymphoma.
Ding JJ; Chen YL; Zhou SH; Zhao K
J Int Med Res; 2018 Dec; 46(12):4920-4929. PubMed ID: 30328364
[TBL] [Abstract][Full Text] [Related]
26. Expression of the multidrug resistance protein MRP and the lung-resistance protein LRP in nasal NK/T cell lymphoma: further exploring the role of P53 and WT1 gene.
Huang WT; Huang CC; Weng SW; Eng HL
Pathology; 2009 Feb; 41(2):127-32. PubMed ID: 18972317
[TBL] [Abstract][Full Text] [Related]
27. EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity.
Yan J; Ng SB; Tay JL; Lin B; Koh TL; Tan J; Selvarajan V; Liu SC; Bi C; Wang S; Choo SN; Shimizu N; Huang G; Yu Q; Chng WJ
Blood; 2013 May; 121(22):4512-20. PubMed ID: 23529930
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-150 enhances radiosensitivity by inhibiting the AKT pathway in NK/T cell lymphoma.
Wu SJ; Chen J; Wu B; Wang YJ; Guo KY
J Exp Clin Cancer Res; 2018 Jan; 37(1):18. PubMed ID: 29386059
[TBL] [Abstract][Full Text] [Related]
29. [Expression and significance of p53-related proteins and LMP-1 in nasal NK/T-cell lymphoma].
Xu G; Wang HF; He G; Xie K
Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):351-5. PubMed ID: 19799083
[TBL] [Abstract][Full Text] [Related]
30. Hypermethylation of PRDM1/Blimp-1 promoter in extranodal NK/T-cell lymphoma, nasal type: an evidence of predominant role in its downregulation.
Zhang Z; Liang L; Li D; Nong L; Liu J; Qu L; Zheng Y; Zhang B; Li T
Hematol Oncol; 2017 Dec; 35(4):645-654. PubMed ID: 27704586
[TBL] [Abstract][Full Text] [Related]
31. The heat-shock protein 90 inhibitor, geldanamycin, induces apoptotic cell death in Epstein-Barr virus-positive NK/T-cell lymphoma by Akt down-regulation.
Jeon YK; Park CH; Kim KY; Li YC; Kim J; Kim YA; Paik JH; Park BK; Kim CW; Kim YN
J Pathol; 2007 Oct; 213(2):170-9. PubMed ID: 17768706
[TBL] [Abstract][Full Text] [Related]
32. miRNA expression profiling of Epstein-Barr virus-associated NKTL cell lines by Illumina deep sequencing.
Alles J; Menegatti J; Motsch N; Hart M; Eichner N; Reinhardt R; Meister G; Grässer FA
FEBS Open Bio; 2016 Apr; 6(4):251-63. PubMed ID: 27239439
[TBL] [Abstract][Full Text] [Related]
33. Circulating Epstein-Barr virus-encoded micro-RNAs as potential biomarkers for nasal natural killer/T-cell lymphoma.
Komabayashi Y; Kishibe K; Nagato T; Ueda S; Takahara M; Harabuchi Y
Hematol Oncol; 2017 Dec; 35(4):655-663. PubMed ID: 27709652
[TBL] [Abstract][Full Text] [Related]
34. ATP-binding cassette sub-family C member 4 (ABCC4) is overexpressed in human NK/T-cell lymphoma and regulates chemotherapy sensitivity: Potential as a functional therapeutic target.
Zhang X; Zhao L; Li X; Wang X; Li L; Fu X; Sun Z; Li Z; Nan F; Chang Y; Zhang M
Leuk Res; 2015 Dec; 39(12):1448-54. PubMed ID: 26499190
[TBL] [Abstract][Full Text] [Related]
35. MYC stimulates EZH2 expression by repression of its negative regulator miR-26a.
Sander S; Bullinger L; Klapproth K; Fiedler K; Kestler HA; Barth TF; Möller P; Stilgenbauer S; Pollack JR; Wirth T
Blood; 2008 Nov; 112(10):4202-12. PubMed ID: 18713946
[TBL] [Abstract][Full Text] [Related]
36. Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma.
Li YX; Liu QF; Fang H; Qi SN; Wang H; Wang WH; Song YW; Lu J; Jin J; Wang SL; Liu YP; Lu N; Liu XF; Yu ZH
Clin Cancer Res; 2009 Apr; 15(8):2905-12. PubMed ID: 19318493
[TBL] [Abstract][Full Text] [Related]
37. Association of miR-34a-3p/5p, miR-141-3p/5p, and miR-24 in Decidual Natural Killer Cells with Unexplained Recurrent Spontaneous Abortion.
Li D; Li J
Med Sci Monit; 2016 Mar; 22():922-9. PubMed ID: 26996957
[TBL] [Abstract][Full Text] [Related]
38. miR-1224 contributes to ischemic stroke-mediated natural killer cell dysfunction by targeting Sp1 signaling.
Feng Y; Li Y; Zhang Y; Zhang BH; Zhao H; Zhao X; Shi FD; Jin WN; Zhang XA
J Neuroinflammation; 2021 Jun; 18(1):133. PubMed ID: 34118948
[TBL] [Abstract][Full Text] [Related]
39. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
[TBL] [Abstract][Full Text] [Related]
40. Aggressive natural killer cell leukemia or extranodal NK/T cell lymphoma? a case with nasal involvement.
Jin X; Xu Y; Zhang J; Li G; Huang D; Yang Y; He H
Diagn Pathol; 2017 Jun; 12(1):46. PubMed ID: 28623913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
